MedTrace Logo

MyTPill: A Novel Strategy to Monitor Antiretroviral Adherence Among HIV+ Prescription Opioid Users

NCT03978793 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 31

Last updated 2025-08-03

No results posted yet for this study

Summary

This study compares several different antiretroviral adherence measures, including digital pills, in HIV+ individuals who are maintained on opioid analgesics.

Conditions

  • HIV-positive Individuals

Interventions

DEVICE

MyTPill, a digital pill

MyTPill is a digital pill containing an approved medication

Sponsors & Collaborators

  • University of Miami

    collaborator OTHER

  • The Miriam Hospital

    collaborator OTHER

  • Massachusetts General Hospital

    collaborator OTHER

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH

  • Florida International University

    collaborator OTHER

  • Ohio State University

    lead OTHER

Principal Investigators

  • Edward W Boyer, MD PhD · Ohio State University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-01
Primary Completion
2025-03-12
Completion
2025-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03978793 on ClinicalTrials.gov